News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
138,528 Results
Type
Article (4750)
Company Profile (18)
Press Release (133760)
Section
Business (40905)
Career Advice (103)
Deals (7075)
Drug Delivery (5)
Drug Development (18144)
Employer Resources (5)
FDA (4986)
Job Trends (3197)
News (72630)
Policy (6166)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (2)
2024 Pharm Country Digital (2)
2026 BioCapital Elite (1)
Academia (503)
Accelerated approval (1)
Allergies (22)
Alliances (15561)
ALS (9)
Alzheimer's disease (283)
Antibody-drug conjugate (ADC) (21)
Approvals (5029)
Artificial intelligence (49)
Autoimmune disease (1)
Automation (8)
Bankruptcy (29)
Best Places to Work (2807)
BIOSECURE Act (2)
Biosimilars (25)
Biotechnology (9)
Bladder cancer (11)
Brain cancer (7)
Breast cancer (62)
Cancer (467)
Cardiovascular disease (34)
Career advice (99)
Career pathing (1)
CAR-T (25)
Cell therapy (84)
Cervical cancer (7)
Clinical research (15762)
Collaboration (257)
Compensation (6)
Complete response letters (1)
COVID-19 (444)
CRISPR (12)
C-suite (37)
Cystic fibrosis (29)
Data (424)
Decentralized trials (1)
Depression (7)
Diabetes (45)
Diagnostics (1682)
Digital health (3)
Drug discovery (17)
Drug pricing (4)
Drug shortages (1)
Duchenne muscular dystrophy (20)
Earnings (13481)
Editorial (4)
Employer branding (1)
Employer resources (4)
Events (15791)
Executive appointments (123)
FDA (5253)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Funding (128)
Gene editing (20)
Generative AI (3)
Gene therapy (55)
GLP-1 (98)
Government (445)
Grass and pollen (2)
Guidances (13)
Healthcare (3775)
Huntington's disease (1)
IgA nephropathy (11)
Immunology and inflammation (11)
Indications (9)
Infectious disease (483)
Inflammatory bowel disease (28)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (22)
Interviews (15)
IPO (2223)
IRA (3)
Job creations (542)
Job search strategy (86)
Kidney cancer (1)
Labor market (1)
Layoffs (42)
Legal (985)
Liver cancer (21)
Lung cancer (87)
Lymphoma (36)
Management (1)
Manufacturing (58)
MASH (11)
Medical device (3333)
Medtech (3334)
Mergers & acquisitions (4970)
Metabolic disorders (89)
Multiple sclerosis (24)
NASH (2)
Neurodegenerative disease (16)
Neuropsychiatric disorders (4)
Neuroscience (392)
NextGen: Class of 2025 (1087)
Non-profit (1021)
Northern California (417)
Now hiring (1)
Obesity (40)
Opinion (14)
Ovarian cancer (16)
Pain (11)
Pancreatic cancer (11)
Parkinson's disease (44)
Partnered (1)
Patents (37)
Patient recruitment (28)
Peanut (12)
People (9873)
Pharmaceutical (9)
Phase I (3814)
Phase II (6259)
Phase III (6494)
Pipeline (184)
Podcasts (1)
Policy (6)
Postmarket research (685)
Preclinical (1221)
Press Release (59)
Prostate cancer (32)
Psychedelics (3)
Radiopharmaceuticals (63)
Rare diseases (88)
Real estate (1192)
Recruiting (3)
Regulatory (5151)
Reports (6)
Research institute (491)
Resumes & cover letters (12)
Rett syndrome (1)
RSV (11)
Schizophrenia (11)
Series A (31)
Series B (8)
Service/supplier (3)
Sickle cell disease (17)
Southern California (329)
Special edition (1)
Sponsored (1)
Startups (613)
Stomach cancer (2)
Supply chain (11)
The Weekly (1)
United States (3615)
Vaccines (137)
Venture capitalists (3)
Webinars (2)
Weight loss (16)
Women's health (8)
Date
Today (19)
Last 7 days (133)
Last 30 days (596)
Last 365 days (6887)
2025 (1341)
2024 (6964)
2023 (7918)
2022 (10533)
2021 (11496)
2020 (11121)
2019 (9337)
2018 (7332)
2017 (7301)
2016 (7052)
2015 (8415)
2014 (5875)
2013 (4927)
2012 (5759)
2011 (5998)
2010 (5190)
Location
Africa (140)
Alabama (6)
Arizona (22)
Arkansas (4)
Asia (10545)
Australia (1364)
California (923)
Canada (287)
China (187)
Colorado (48)
Connecticut (54)
Delaware (41)
Europe (23970)
Florida (112)
Georgia (51)
Idaho (7)
Illinois (108)
India (9)
Indiana (46)
Japan (40)
Kansas (13)
Kentucky (2)
Louisiana (2)
Maine (1)
Maryland (109)
Massachusetts (574)
Michigan (42)
Minnesota (81)
Mississippi (1)
Missouri (12)
Montana (6)
Nebraska (6)
Nevada (16)
New Hampshire (24)
New Jersey (422)
New Mexico (2)
New York (231)
North Carolina (204)
North Dakota (4)
Northern California (417)
Ohio (40)
Oklahoma (3)
Oregon (7)
Pennsylvania (237)
Puerto Rico (1)
Rhode Island (4)
South America (198)
South Carolina (1)
Southern California (329)
Tennessee (11)
Texas (106)
Utah (31)
Virginia (26)
Washington D.C. (7)
Washington State (85)
West Virginia (1)
Wisconsin (10)
138,528 Results for "clinipace worldwide".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene therapy
Pfizer Axes Beqvez Worldwide, Pivoting Away From Gene Therapy for Hemophilia
The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.
February 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zetagen Therapeutics Expands IP Portfolio, Achieving a Milestone of 64 Worldwide Patents in 2024
January 8, 2025
·
3 min read
Press Releases
Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma
February 13, 2025
·
7 min read
Drug Development
Worldwide Clinical Trials Recognized as Highest Rated Phase I Provider for Overall User Preference in 2024 Industry Standard Research Phase I Benchmarking Report
Worldwide Clinical Trials (Worldwide), a global full-service contract research organization (CRO), proudly announces results of the 2024 Industry Standard Research (ISR) Phase I CRO Benchmarking Report.
June 25, 2024
·
4 min read
Press Releases
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
March 12, 2025
·
7 min read
Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment
Enzolytics, Inc. (OTC PINK:ENZC) (“enzolytics.com”) (the “Company”) announced today that the Company is entering into a worldwide exclusive licensing agreement for US Patent # 8067531-B2, “Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells,” applying Immunotherapy Treatment to the global fight against cancer.
July 1, 2024
·
7 min read
Press Releases
Streck to distribute Ceres NEAT Liquid Biopsy Kit - Streck BCT worldwide
November 18, 2024
·
2 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
BioMidwest
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
Xeris Biopharma Holdings, Inc. announced that it has entered into an exclusive worldwide collaboration and license agreement with Beta Bionics, Inc. for the development and commercialization of a glucagon product utilizing Xeris’ XeriSol™ technology for use in Beta Bionics’ proprietary bi-hormonal pump and pump systems.
May 6, 2024
·
6 min read
Press Releases
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
December 23, 2024
·
3 min read
1 of 13,853
Next
